Today's Date
Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
(
STAYCIS
)
ITN Protocol #:
ITN020AI
Branded Name:
STAYCIS
ClinicalTrials.Gov ID:
NCT00094172Treatment Protocol #:
Therapeutic Area:
Autoimmune Disease
Current Status:
Complete
Summary:
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Atorvastatin in Patients With Clinically Isolated Syndrome and High Risk of Conversion to Multiple Sclerosis
Clinical Operations Manager
NIAID Project Manager
Rho Scientist
Study Personnel:
